Eosinophilic Asthma Resource Centre

Welcome, this website is intended for all international healthcare professionals. By clicking the link below you are declaring and confirming that you are a healthcare professional.

You are here

Switching Targeted Therapy in Eosinophilic Asthma: Anti-IgE or Anti-IL-5

Interactive Patient Case

In this interactive case study, you will have the opportunity to explore a specific patient case in depth and learn more about management of eosinophilic asthma using the newest targeted therapies

Learning objectives

Following completion, you should be able to:

  • Identify different characteristics commonly associated with eosinophilic asthma
  • Be familiar with the differences between anti-IgE and anti-IL-5 biologicals in their mechanism of action
  • Recognize patients who do not respond well to specific biologicals
  • Describe the clinical efficacy and safety of IL-5 targeted agents in the treatment of eosinophilic asthma

E-Alert

Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre.

Search this site

ERS 2017 Congress Highlights

Featured Video Presentation

Share